JP2022548875A5 - - Google Patents
Info
- Publication number
- JP2022548875A5 JP2022548875A5 JP2022516404A JP2022516404A JP2022548875A5 JP 2022548875 A5 JP2022548875 A5 JP 2022548875A5 JP 2022516404 A JP2022516404 A JP 2022516404A JP 2022516404 A JP2022516404 A JP 2022516404A JP 2022548875 A5 JP2022548875 A5 JP 2022548875A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- salt
- ascorbic acid
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025176508A JP2026031934A (ja) | 2019-09-16 | 2025-10-20 | 安定した濃縮放射性医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19197607 | 2019-09-16 | ||
| EP19197607.5 | 2019-09-16 | ||
| PCT/EP2020/075767 WO2021052960A1 (en) | 2019-09-16 | 2020-09-15 | Stable, concentrated radiopharmaceutical composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025176508A Division JP2026031934A (ja) | 2019-09-16 | 2025-10-20 | 安定した濃縮放射性医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548875A JP2022548875A (ja) | 2022-11-22 |
| JP2022548875A5 true JP2022548875A5 (enExample) | 2023-09-25 |
| JP7762648B2 JP7762648B2 (ja) | 2025-10-30 |
Family
ID=67981980
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516404A Active JP7762648B2 (ja) | 2019-09-16 | 2020-09-15 | 安定した濃縮放射性医薬組成物 |
| JP2025176508A Pending JP2026031934A (ja) | 2019-09-16 | 2025-10-20 | 安定した濃縮放射性医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025176508A Pending JP2026031934A (ja) | 2019-09-16 | 2025-10-20 | 安定した濃縮放射性医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220401593A1 (enExample) |
| EP (1) | EP4031193A1 (enExample) |
| JP (2) | JP7762648B2 (enExample) |
| KR (1) | KR20220063218A (enExample) |
| CN (1) | CN114728088A (enExample) |
| AR (1) | AR119974A1 (enExample) |
| AU (1) | AU2020349002B2 (enExample) |
| CA (1) | CA3154302A1 (enExample) |
| IL (1) | IL291315A (enExample) |
| TW (1) | TW202123976A (enExample) |
| WO (1) | WO2021052960A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250032652A1 (en) * | 2021-11-30 | 2025-01-30 | Nihon Medi-Physics Co., Ltd. | Stabilized radiopharmaceutical composition |
| CN114404618A (zh) * | 2022-03-28 | 2022-04-29 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其用途 |
| CN114404619A (zh) * | 2022-03-28 | 2022-04-29 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其制备方法和用途 |
| CN116920129A (zh) * | 2022-04-02 | 2023-10-24 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其制备方法和用途 |
| EP4661919A1 (en) | 2023-02-08 | 2025-12-17 | Novartis AG | Methods for treating glioblastoma |
| JP2026506981A (ja) | 2023-02-23 | 2026-02-27 | ノバルティス アーゲー | 乳癌を治療するための方法 |
| WO2025058000A1 (ja) | 2023-09-13 | 2025-03-20 | 東レ株式会社 | 癌の治療、予防及び／又は診断用医薬組成物 |
| WO2025126151A1 (en) | 2023-12-15 | 2025-06-19 | Novartis Ag | Methods for treating breast cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG177216A1 (en) * | 2003-07-24 | 2012-01-30 | Bracco Imaging Spa | Stable radiopharmaceutical compositions and methods for their preparation |
| WO2008009444A1 (en) | 2006-07-19 | 2008-01-24 | Van Dulmen, Adrianus, A. | Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide |
| LT2900279T (lt) | 2012-09-25 | 2019-11-11 | Advanced Accelerator Applications Usa Inc | Grpr antagonistai, skirti grpr atžvilgiu teigiamo vėžio nustatymui, diagnozavimui ir gydymui |
-
2020
- 2020-09-15 JP JP2022516404A patent/JP7762648B2/ja active Active
- 2020-09-15 WO PCT/EP2020/075767 patent/WO2021052960A1/en not_active Ceased
- 2020-09-15 US US17/753,762 patent/US20220401593A1/en active Pending
- 2020-09-15 AR ARP200102561A patent/AR119974A1/es unknown
- 2020-09-15 EP EP20768373.1A patent/EP4031193A1/en active Pending
- 2020-09-15 KR KR1020227012069A patent/KR20220063218A/ko active Pending
- 2020-09-15 CA CA3154302A patent/CA3154302A1/en active Pending
- 2020-09-15 CN CN202080079709.9A patent/CN114728088A/zh active Pending
- 2020-09-15 TW TW109131644A patent/TW202123976A/zh unknown
- 2020-09-15 AU AU2020349002A patent/AU2020349002B2/en active Active
-
2022
- 2022-03-13 IL IL291315A patent/IL291315A/en unknown
-
2025
- 2025-06-11 US US19/234,864 patent/US20250332301A1/en active Pending
- 2025-10-20 JP JP2025176508A patent/JP2026031934A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200222562A1 (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| Roesch et al. | The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry | |
| JP2023552180A5 (enExample) | ||
| JP2023514784A (ja) | 放射性金属用キレート剤組成物およびその使用方法 | |
| WO2004069285A1 (en) | Improved radiometal complex compositions | |
| JP2008195715A5 (enExample) | ||
| AU2020268836B2 (en) | Para-aminohippuric acid (PAH) as a renal protective substance | |
| Sanad et al. | Radiodiagnosis of peptic ulcer with technetium-99 m-labeled esomeprazole | |
| JP2012533523A5 (enExample) | ||
| JP2022532187A5 (enExample) | ||
| US20260053959A1 (en) | Methods for large scale synthesis of radionuclide complexes | |
| BR112014003336B1 (pt) | processo para a preparação de complexos de 68 ga, kit de reação e frasco para uso no referido processo | |
| Zhernosekov et al. | A 140Nd/140Pr radionuclide generator based on physico-chemical transitions in 140Pr complexes after electron capture decay of 140Nd-DOTA | |
| CN115702009A (zh) | 用于放射性标记psma结合配体的方法及其试剂盒 | |
| JP2025510161A5 (enExample) | ||
| JP2022554186A5 (enExample) | ||
| WO2025153102A1 (zh) | 一种环状多肽化合物及其应用 | |
| CN115484991A (zh) | 用于放射性标记psma结合配体的方法及其试剂盒 | |
| WO2025153103A1 (zh) | 一种含氮化合物及其制备方法与用途 | |
| TW202602504A (zh) | 放射性醫藥化合物之改良配方 | |
| WO2025153101A1 (zh) | 一种含氮化合物及其制备方法与用途 | |
| JP2024539952A5 (enExample) | ||
| JP2005112750A (ja) | 腎臓トランスポーターによる薬物動態の制御方法および製剤 | |
| HK1167344A (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| HK1167344B (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid |